Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Sep. 30, 2025	Dec. 31, 2024
Current Assets:
Cash and cash equivalents	$ 1,292.7	$ 525.5
Accounts receivable, less allowance for credit losses	1,598.3	1,480.7
Inventories	2,483.7	2,235.3
Prepaid expenses and other current assets	460.3	430.1
Total Current Assets	5,834.9	4,671.5
Property, plant and equipment, net	2,194.3	2,048.8
Goodwill	9,702.0	8,951.1
Intangible assets, net	4,739.7	4,598.4
Other assets	1,017.2	1,095.5
Total Assets	23,488.0	21,365.3
Current Liabilities:
Accounts payable	315.3	194.6
Other current liabilities	1,487.6	1,393.3
Current portion of long-term debt	600.0	863.0
Total Current Liabilities	2,402.9	2,450.9
Other long-term liabilities	806.4	1,096.6
Long-term debt	7,512.6	5,341.6
Total Liabilities	10,722.0	8,889.1
Commitments and Contingencies (Note 15)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 318.7 million shares as of September 30, 2025 (317.5 million as of December 31, 2024) issued	3.2	3.2
Paid-in capital	10,155.5	10,038.1
Retained earnings	11,518.6	11,095.3
Accumulated other comprehensive loss	(283.8)	(262.8)
Treasury stock, 120.5 million shares as of September 30, 2025 (118.4 million as of December 31, 2024)	(8,637.0)	(8,405.7)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,756.5	12,468.1
Noncontrolling interest	9.5	8.1
Total Stockholders' Equity	12,766.0	12,476.2
Total Liabilities and Stockholders' Equity	$ 23,488.0	$ 21,365.3